Accessibility Menu
TetraLogic Pharmaceuticals logo

TetraLogic Pharmaceuticals

(OTC) TLOG

Current Price$0.00
Market Cap$1.00K
Since IPO (2013)-100%
5 Year-100%
1 Year-60%
1 Month-80%

TetraLogic Pharmaceuticals Financials at a Glance

Market Cap

$1.00K

Revenue (TTM)

$0.00

Net Income (TTM)

-$45.76M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

21.10 (High)

Price

$0.00

Volume

500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Feb 28, 2025

TLOG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TetraLogic Pharmaceuticals

Industry

Biotechnology

Headquarters

Malvern, PA 19355, US

TLOG Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-75%

Return on Assets

-88%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.00K

Shares Outstanding

24.46M

Volume

500

Avg. Volume

31.25

Financials (TTM)

Gross Profit

-$187.99K

Operating Income

-$44.99M

EBITDA

-$43.15M

Operating Cash Flow

-$34.89M

Capital Expenditure

-$77.33K

Free Cash Flow

-$34.97M

Cash & ST Invst.

$20.41M

Total Debt

$28.28M

TetraLogic Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2016YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.00K

N/A

Market Cap/Employee

$34.48

N/A

Employees

29

N/A

Net Income

-$8.63M

+30.9%

EBITDA

-$9.18M

+0.6%

Quarterly Fundamentals

Name
Q3 2016YOY CHG

Total Cash

$5.89M

-80.1%

Total Debt

$30.81M

+6.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$30.79M

+6.9%

Short Term Debt

$0.00

N/A

Return on Assets

-87.64%

N/A

Return on Invested Capital

-74.54%

N/A

Free Cash Flow

-$2.79M

+63.7%

Operating Cash Flow

-$2.79M

+63.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CALACalithera Biosciences, Inc.
$0.00+0.00%
TNGNQTengion, Inc.
$0.00+0.00%
KLDOKaleido Biosciences, Inc.
$0.00+0.00%
BXRXQBaudax Bio, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CDECoeur Mining
$17.51-0.00%
AALAmerican Airlines Group
$15.99+0.04%
NOKNokia
$13.49-0.02%
PFEPfizer
$25.21-0.03%

Questions About TLOG

What is the current price of TetraLogic Pharmaceuticals?

TetraLogic Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for TetraLogic Pharmaceuticals?

Over the past 52 weeks, TetraLogic Pharmaceuticals has traded between $0.00 and $0.00.

How much debt does TetraLogic Pharmaceuticals have?

TetraLogic Pharmaceuticals total debt is unavailable.

How much cash does TetraLogic Pharmaceuticals have on hand?

TetraLogic Pharmaceuticals does not have cash on hand data available.

What is TetraLogic Pharmaceuticals’s dividend yield?

TetraLogic Pharmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.